M S K, Rajaguru H, Nair A
Bioengineering (Basel). 2023; 10(8).
PMID: 37627818
PMC: 10451477.
DOI: 10.3390/bioengineering10080933.
Bardelli F, Giacobbe C, Ballirano P, Borelli V, Di Benedetto F, Montegrossi G
Environ Geochem Health. 2023; 45(7):5039-5051.
PMID: 37058192
PMC: 10310571.
DOI: 10.1007/s10653-023-01557-0.
Baur X, Frank A
J Occup Med Toxicol. 2021; 16(1):6.
PMID: 33622366
PMC: 7901213.
DOI: 10.1186/s12995-021-00295-2.
Giacobbe C, Di Giuseppe D, Zoboli A, Gualtieri M, Bonasoni P, Moliterni A
IUCrJ. 2021; 8(Pt 1):76-86.
PMID: 33520244
PMC: 7792997.
DOI: 10.1107/S2052252520015079.
Frank A
J Occup Med Toxicol. 2020; 15:16.
PMID: 32549902
PMC: 7294762.
DOI: 10.1186/s12995-020-00267-y.
In vitro acellular dissolution of mineral fibres: A comparative study.
Gualtieri A, Pollastri S, Bursi Gandolfi N, Gualtieri M
Sci Rep. 2018; 8(1):7071.
PMID: 29728675
PMC: 5935704.
DOI: 10.1038/s41598-018-25531-4.
Carbon Nanotube and Asbestos Exposures Induce Overlapping but Distinct Profiles of Lung Pathology in Non-Swiss Albino CF-1 Mice.
Frank E, Carreira V, Birch M, Yadav J
Toxicol Pathol. 2016; 44(2):211-25.
PMID: 26839332
PMC: 4976500.
DOI: 10.1177/0192623315620587.
Role of hemoglobin and transferrin in multi-wall carbon nanotube-induced mesothelial injury and carcinogenesis.
Wang Y, Okazaki Y, Shi L, Kohda H, Tanaka M, Taki K
Cancer Sci. 2015; 107(3):250-7.
PMID: 26679080
PMC: 4814253.
DOI: 10.1111/cas.12865.
How conflicted authors undermine the World Health Organization (WHO) campaign to stop all use of asbestos: spotlight on studies showing that chrysotile is carcinogenic and facilitates other non-cancer asbestos-related diseases.
Baur X, Soskolne C, Lemen R, Schneider J, Woitowitz H, Budnik L
Int J Occup Environ Health. 2015; 21(2):176-9.
PMID: 25729927
PMC: 4457129.
DOI: 10.1179/2049396714Y.0000000105.
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic.
Roe O, Stella G
Eur Respir Rev. 2015; 24(135):115-31.
PMID: 25726562
PMC: 9487774.
DOI: 10.1183/09059180.00007014.
Letter to the editor.
Greek R
Theor Med Bioeth. 2014; 35(5):389-94.
PMID: 25179121
DOI: 10.1007/s11017-014-9305-5.
Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling.
Qi F, Okimoto G, Jube S, Napolitano A, Pass H, Laczko R
Am J Pathol. 2013; 183(5):1654-66.
PMID: 24160326
PMC: 3814524.
DOI: 10.1016/j.ajpath.2013.07.029.
Comment on 'estimating the asbestos-related lung cancer burden from mesothelioma mortality' - IARC and chrysotile risks.
Lemen R, Frank A, Soskolne C, Weiss S, Castleman B
Br J Cancer. 2013; 109(3):823-5.
PMID: 23807166
PMC: 3738123.
DOI: 10.1038/bjc.2013.301.
Health risk of chrysotile revisited.
Bernstein D, Dunnigan J, Hesterberg T, Brown R, Legaspi Velasco J, Barrera R
Crit Rev Toxicol. 2013; 43(2):154-83.
PMID: 23346982
PMC: 3581056.
DOI: 10.3109/10408444.2012.756454.
A short history of the toxicology of inhaled particles.
Donaldson K, Seaton A
Part Fibre Toxicol. 2012; 9:13.
PMID: 22559156
PMC: 3436721.
DOI: 10.1186/1743-8977-9-13.
Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases.
Huang S, Jaurand M, Kamp D, Whysner J, Hei T
J Toxicol Environ Health B Crit Rev. 2011; 14(1-4):179-245.
PMID: 21534089
PMC: 3118525.
DOI: 10.1080/10937404.2011.556051.
Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.
Mossman B, Lippmann M, Hesterberg T, Kelsey K, Barchowsky A, Bonner J
J Toxicol Environ Health B Crit Rev. 2011; 14(1-4):76-121.
PMID: 21534086
PMC: 3118517.
DOI: 10.1080/10937404.2011.556047.
Applying definitions of "asbestos" to environmental and "low-dose" exposure levels and health effects, particularly malignant mesothelioma.
Case B, Abraham J, Meeker G, Pooley F, Pinkerton K
J Toxicol Environ Health B Crit Rev. 2011; 14(1-4):3-39.
PMID: 21534084
PMC: 3118487.
DOI: 10.1080/10937404.2011.556045.
Mechanisms of asbestos-induced carcinogenesis.
Toyokuni S
Nagoya J Med Sci. 2009; 71(1-2):1-10.
PMID: 19358470
PMC: 11166392.
Role of iron in carcinogenesis: cancer as a ferrotoxic disease.
Toyokuni S
Cancer Sci. 2008; 100(1):9-16.
PMID: 19018762
PMC: 11158384.
DOI: 10.1111/j.1349-7006.2008.01001.x.